Product Defects and Supply Disruptions
First written in FY2020. 3 of 4 entries say "Restated". Latest entry: FY2024.
5 other companies' latest entry also says "Restated".
- FY2024RestatedAnnual report
「No serious defects or similar issues have occurred to date. However, if a serious defect or similar issue were to arise in a product being deployed due to special circumstances, requiring a substantial amount of work to remedy, or if new supplies were disrupted, this could affect the Company’s financial position and operating results.」
While stating that no serious product defects or supply disruptions have occurred, the residual risk in quality control continues. - FY2022RestatedAnnual report
「No serious defects or similar issues have occurred to date. However, if a serious defect or similar issue were to arise in a product being deployed due to special circumstances, requiring a substantial amount of work to remedy, or if new supplies were disrupted, this could affect the Company’s financial position and operating results.」
While stating that no serious product defects or supply disruptions have occurred, the residual risk in quality control is reiterated. - FY2021RestatedAnnual report
「No serious defects or similar issues have occurred to date. However, if a serious defect or similar issue were to arise in a product being deployed due to special circumstances, requiring a substantial amount of work to remedy, or if new supplies were disrupted, this could affect the Company’s financial position and operating results.」
The residual risk in quality control is reiterated, including the explanation that no serious product defects or supply disruptions have occurred. - FY2020First statedAnnual report
「No serious defects or similar issues have occurred to date. However, if a serious defect or similar issue were to arise in a product being deployed due to special circumstances, requiring a substantial amount of work to remedy, or if new supplies were disrupted, this could affect the Company’s financial position and operating results.」
While quality control for internally developed products is being conducted, the possibility of serious defects is identified as a residual risk.